Stomati M, Bersi C, Bernardi F, Rubino S, Nappi L, Catarsi S, Ferrari A, Spinetti A, Cionini R, Petraglia F, Genazzani A R
Department of Obstetrics and Gynecology, University of Pisa, Italy.
Gynecol Endocrinol. 1998 Feb;12(1):35-40. doi: 10.3109/09513599809024968.
Beta-endorphin (beta-EP) is a neuropeptide involved in several brain functions, regulating the reproductive axis and behavioral changes. Estrogens play a modulatory role on circulating levels of beta-EP in women. Previous clinical studies have demonstrated high plasma beta-EP levels in obese subjects and increased beta-EP release after an oral glucose tolerance test (OGTT) in normal or obese women. The aim of the present study was to evaluate plasma beta-endorphin levels in response to an OGTT in pre- and postmenopausal obese and non-obese women, in order to investigate if the decrease in gonadal steroid levels at menopause could modify in a different manner the control of beta-endorphin release in response to glucose administration. A group of 24 normal women (age range 45-55 years) were included in the study. The patients were subdivided in four groups of six subjects each: group A, premenopausal women with body mass index (BMI) < 25 (control); group B, premenopausal women with BMI > 25 (obese); group C, post-menopausal women with BMI < 25 (control); group D, postmenopausal women with BMI > 25 (obese). All women were studied between 8.30 and 9.00 am, after overnight fasting, and underwent an OGTT. In obese premenopausal women, basal plasma beta-EP levels were significantly higher than in non-obese women (p < 0.01). In postmenopausal women, regardless of body weight, low basal plasma beta-EP levels were found. A significant increase in plasma beta-EP levels, at 30 and 60 minutes after oral glucose ingestion, was shown in control premenopausal women. No significant modifications to OGTT were shown in plasma beta-EP levels in the other three groups of women. In conclusion, while in premenopausal women the response of plasma beta-EP levels to OGTT is maintained, in postmenopause there is a lack of response to OGTT. This suggests that beta-EP release is dependent upon gonadal steroids, while it is only in part influenced by body weight.
β-内啡肽(β-EP)是一种参与多种脑功能的神经肽,可调节生殖轴和行为变化。雌激素对女性循环中的β-EP水平起调节作用。先前的临床研究表明,肥胖受试者血浆β-EP水平较高,正常或肥胖女性口服葡萄糖耐量试验(OGTT)后β-EP释放增加。本研究的目的是评估绝经前和绝经后肥胖及非肥胖女性对OGTT的血浆β-内啡肽水平反应,以调查绝经时性腺类固醇水平的降低是否会以不同方式改变对葡萄糖给药的β-内啡肽释放控制。一组24名正常女性(年龄范围45 - 55岁)被纳入研究。患者被分为四组,每组6名受试者:A组,体重指数(BMI)< 25的绝经前女性(对照组);B组,BMI > 25的绝经前女性(肥胖组);C组,BMI < 25的绝经后女性(对照组);D组,BMI > 25的绝经后女性(肥胖组)。所有女性均在上午8:30至9:00之间进行研究,经过一夜禁食后接受OGTT。在肥胖绝经前女性中,基础血浆β-EP水平显著高于非肥胖女性(p < 0.01)。在绝经后女性中,无论体重如何,基础血浆β-EP水平均较低。对照组绝经前女性口服葡萄糖后30分钟和60分钟时,血浆β-EP水平显著升高。其他三组女性的血浆β-EP水平对OGTT无显著变化。总之,绝经前女性血浆β-EP水平对OGTT的反应得以维持,而绝经后则对OGTT缺乏反应。这表明β-EP的释放依赖于性腺类固醇,而仅部分受体重影响。